You are too funny but thanks for the kind words!! @sabcs.bsky.social is our opportunity to spread the word about @bsky.app

Dr. RShatsky@dr-rshatsky.bsky.social · 2y ago

She’s here guys she’s here!! 🥰🥰 My beloved @hoperugo.bsky.social has joined the party!!! #bcsm take note. Our mamma bear has arrived!

Great news - post #sabcs24 on bsky.social! This is the way to get our colleagues and friends on board. @sabcs.bsky.social @oncoalert.bsky.social

Bluesky

Social media as it should be. Find your community among millions of users, unleash your creativity, and have some fun again.

bsky.social

Stacey Tinianov, MPH@coffeemommy.bsky.social · 2y ago

WOOT! Just in time for #SABCS24 looks like @sabcs.bsky.social is officially on BlueSky! cc: @maryamlustberg.bsky.social @drsgraff.bsky.social @stage4kelly.bsky.social @amjohnston.bsky.social @amybeumer.bsky.social @raalbany.bsky.social @hoperugo.bsky.social

We need to get the oncology community on board! Can’t deal with X!!

Kelly Shanahan@stage4kelly.bsky.social · 2y ago

@hoperugo.bsky.social glad to see you here!!

Have to share this beautiful photo. @oncoalert.bsky.social

Martin Rak@martinrak.bsky.social · 2y ago

Morning blues in the Dolomites.

Thanks for posting! A favorite activity is the recordings I do with Sara Tolaney around new data at our international meetings! @oncoalert.bsky.social @ucsfcancer.bsky.social

Mauricio Z Baptista@mzbaptista.bsky.social · 2y ago

📣JUST IN: Dr. Sara Tolaney @danafarber.bsky.social BreastOnc & Dr. Hope Rugo @hoperugo.bsky.social UCSFCancer share insights on Top #SABCS24 abstracts! Watch 📽️ on 👇 tinyurl.com/SABCS24eBC #bcsm #oncsky #medsky #breastcancer

Impact of risk reducing surg for young women with BRCA (Lambertini). Zest (Turner) about ctDNA in high risk early stage disease, what have we learned! of course many more... @oncoalert.bsky.social

@hoperugo.bsky.social · 2y ago

Agree with the list, big data coming up! - a few more here and to follow: COMET, important trial evaluating watch and wait vs surgery for low risk DCIS (Hwang). PADMA: RW study of Pablo/letrozole vs chemo for metastatic disease (Loibl).

Agree with the list, big data coming up! - a few more here and to follow: COMET, important trial evaluating watch and wait vs surgery for low risk DCIS (Hwang). PADMA: RW study of Pablo/letrozole vs chemo for metastatic disease (Loibl).

Paolo Tarantino, MD@ptarantinomd.bsky.social · 2y ago

Only 3 weeks to #SABCS24, a meeting that promises to significantly impact the way we treat breast cancer. It will feature phase 3 data with novel SERDs, novel ADCs, immunotherapy, ctDNA monitoring, important biomarker analyses & so much more. Here’s my top 10 abstracts list— see you in San Antonio!